Acute Events in Hospitalized Patients with Sickle Cell Anemia before and after the Use of Hydroxyurea
Objective: To estimate the occurrence of acute events in hospitalized patients with sickle cell anemia (SCA) before and after the use of hydroxyurea (HU). Method: The study has a quantitative approach, of analytical cohort type developed in two public referral hospitals in the Midwest region of Brazil, from November 2010 to October 2011. Data collection was performed on records of patients diagnosed with SCA. The interval time for the data collection was 30 years, which corresponded between 1980 and 2010. The research was approved by the Ethics Committee of the Federal University of Mato Grosso do Sul, Campo Grande/MS, Brazil, under protocol 1822/2010. Results: The sample had 32 medical records of hospitalized patients diagnosed with SCA who used HU. The mean age of the participants was 25.65±11.92; the average time of drug exposure was 6.0±2.8 years; the average initial dose was 17.00±5,3mg/kg/day and final dose of 22.10±5.3 mg/kg/day. After using HU, the fetal hemoglobin ranged from 8.41±0.95 to 14.44±13.7% (p<0.001). There was a reduction of the average leucocyte, absolute neutrophil, acute events, total infections and blood transfusions. Conclusion: The effects of HU exposure caused an increase in fetal hemoglobin level, decreasing leukocyte, absolute neutrophils and acute events, transfusions and hospitalizations by the use of non-opioid.
Keywords: Sickle Cell Anemia; Hydroxyurea; Infection.
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access and Benefits of Publishing Open Access).